# Female Infertility and Risk for Later-Life Cardiovascular Disease: Lessons from a Mouse Model of Human Cardiovascular Disease

**Authors:** Ayaka Tanaka, Hitomi Nakamura, Namhyo Kim, Hajime Nakaoka, Makoto Nishida, Keiichi Kumasawa, Yasushi Sakata, Shizuya Yamashita, Tadashi Kimura

PMC · DOI: 10.1007/s43032-025-02026-y · Reproductive Sciences · 2026-01-16

## TL;DR

This study explores how female infertility in mice may be linked to later-life cardiovascular disease, suggesting unexplained infertility in women could indicate future heart risks.

## Contribution

The study identifies specific fertility dysfunctions in mice that are associated with cardiovascular disease risk and are reversible with treatment.

## Key findings

- Female mice with CVD-related genetic deficiencies showed infertility due to oocyte degeneration and implantation failure.
- Probucol treatment reduced cholesterol and restored fertility in these mice.
- The findings suggest that infertility caused by oocyte degeneration and uterine dysfunction may be linked to later-life CVD risk.

## Abstract

The potential link between female infertility during reproductive age and an increased risk of cardiovascular disease (CVD) later in life remains controversial. Female fertility is a complex process involving multiple steps, and disruptions at any stage can result in infertility. If only a specific subset of fertility dysfunctions—often challenging to diagnose—is associated with future CVD risk, this relationship may be masked by the heterogeneity of infertility causes. Identifying infertility factors that predispose women to CVD requires careful selection of study populations. To address this, we investigated fertility status in scavenger receptor class B, type I-deficient mice with hypomorphic apolipoprotein E mice, which represent the dominant pathologic foundation for human CVD. These female mice were healthy and active when fed a normal chow diet at reproductive age, but generated no offspring. The dysfunctional female fertility processes identified included degeneration of oocytes during the maturation processes prior to ovulation and impairment of implantation via dysfunctional decidualisation. The administration of probucol, a hypocholesterolaemic agent, significantly decreased the plasma total cholesterol level, as well as the size of high-density lipoprotein-like particles, and these alterations restored female fertility. These findings suggest that infertility caused by degeneration of oocytes during the maturation processes and defective uterine receptivity may contribute to CVD risk later in life. Women with unexplained infertility and recurrent implantation failure may represent an important cohort for future CVD risk assessment.

The online version contains supplementary material available at 10.1007/s43032-025-02026-y.

## Linked entities

- **Chemicals:** probucol (PubChem CID 4912)
- **Diseases:** cardiovascular disease (MONDO:0004995)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Diseases:** Cardiovascular Disease (MESH:D002318)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12992438/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12992438/full.md

## References

1 references — full list in the complete paper: https://tomesphere.com/paper/PMC12992438/full.md

---
Source: https://tomesphere.com/paper/PMC12992438